Effects of Pilates and Burpees Exercises in Core Strengthening and Dynamic Balance.

May 6, 2024 updated by: Riphah International University

Effects of Pilates and Burpees Exercises on Core Strengthening and Dynamic Balance in Cricket Players

This study will be a randomized clinical trial will be conducted in Ayub national park cricket club Sample size will be 48 to evaluate the effects of Pilates and Burpees exercises training among cricket players with an age range of 16-24 years. Non probability convenient sampling technique would be used. Participants will be randomly assigned to 2 groups. Group A will include participants who received Pilates exercises training (6 weeks) along with the warm up. Group B participant who will receive burpees exercise training (6 weeks) and warm up. Outcomes of both trainings are the effects on core strengthening and dynamic balance on players in A group and the B group. Post interventional assessment was done via Star excursion balance test, prone bridge test and 1 minute sit-up test. Data will be collected at baseline and 6 weeks. Data will be analyzed by SPSS version 25

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Cricket is a most popular sport played throughout the world. It is played in three common formats depending on the duration of the game, firstly a Test match is played over 4-5 day's with around 90 overs per day Secondly One day match is shorter with 50 over on each side and the Last one is T-Twenty match much shorter with 20 over on each side. As each format places different physical demands on the players the require an extensive combination of tactics, skills and physical fitness in the form of strength, flexibility and balance. In our study we can focus on the basic core strengthening which is essential for physical fitness and better performance in the game. Primary the aim of this study is to evaluate the comparative effects of Pilates and Burpees exercises of core strengthening and dynamic stability of body in young cricket players

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
48

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Pakistan
    • Punjab
      • Sargodha, Punjab, Pakistan, 40100
        • Abdul Rahman Hashmi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Partipant should be a cricket player.
  • Individual with age group of 16-24 years.
  • Only male players without any history of fracture

Exclusion Criteria:

  • Player who recieved any type of physical therapy session during last 2 months.
  • Any type of soft tissue injury reported.
  • Any type of deformity.
  • Past history of surgical procedures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Baseline warmup along with Pilate exercises
Pilate exercises: Group A perform Pilates exercises for 6 weeks. In the initial stage of training Pilates exercises with lo intensity then we proceeded gradually with high intensity. Pilates was performed for core strengthening and dynamic balance Pelvic curl, The hundred, Side plank with 4-5 rep, 30 sec hold and 3 sets with each exercise.
Other: Pilate exercises
After 10 minutes of warmup excercises, participatants perform pilates exercises, Pelvic curl : 45 seconds hold The Hundred : 45 seconds hold Bird Dog : 45 seconds hold Side plank : 45 seconds hold Frequency 3 days a week intensity 45 minutes hold a pose. Time will be 10 to 15 minutes.
Experimental: : Baseline physical therapy treatment along with burpees exercises
Burpees Exercises: Group B perform Burpees exercises for 6 weeks. In initial weeks of training Burpees exercises with low intensity then we proceeded gradually with high intensity exercises. Burpees was performed for core strengthening and dynamic balance .10 to 15 repetition ,3 sets with rest interval of 10 sec after each set of exercises
Other: Burpees exercises

After 10 minutes of warmup excercises, participatants perform burppes excercises.

  1. Stand straight with your feet shoulder-width apart.
  2. Squat and place your hands in front of your feet.
  3. Jump back until your legs are fully extended and your body is in plank position.
  4. Do a push up, jump forward, and then push through the heels to return to the starting position.
  5. Repeat until the set is complete. Frequency 3 days a week .Time 10 to 15 minutes with 10 reputation , 3 sets. Rest internal will be 10 seconds after each set.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Star excursion balance test:
Time Frame: Pre and 6 week post interventional
Star Excursion Balance test is a dynamic test required for proprioception along with strength and flexibility. It is a measure of dynamic balance providing challenge to athletes and physically active individual
Pre and 6 week post interventional
One min situp test:
Time Frame: Pre and 6 week post interventional
Abdominal muscle strength and endurance is important for core stability and back support. This sit-up test measures the strength and endurance of the abdominals and hip-flexor muscles
Pre and 6 week post interventional
Prone bridges test:
Time Frame: Pre and 6 week post interventional
The prone bridge provides an indication of core abdominal strength.Prior to undertaking this test a member of the Health Promotion Unit will explain the test protocol and provide a demonstration to the group of Applicants
Pre and 6 week post interventional

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Riphah International University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Imran Ghafoor, PhD, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 20, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
February 20, 2024

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
February 20, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 9, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 25, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 9, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 7, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 6, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • REC/RCR & AHS/23/0458

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings